BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14625032)

  • 1. Trans-sodium crocetinate increases oxygen delivery to brain parenchyma in rats on oxygen supplementation.
    Okonkwo DO; Wagner J; Melon DE; Alden T; Stone JR; Helm GA; Jane JA
    Neurosci Lett; 2003 Dec; 352(2):97-100. PubMed ID: 14625032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigation.
    Manabe H; Okonkwo DO; Gainer JL; Clarke RH; Lee KS
    J Neurosurg; 2010 Oct; 113(4):802-9. PubMed ID: 19961314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of trans sodium crocetinate on brain tumor oxygenation. Laboratory investigation.
    Sheehan J; Sherman J; Cifarelli C; Jagannathan J; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2009 Aug; 111(2):226-9. PubMed ID: 19326986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic stroke.
    Wang Y; Yoshimura R; Manabe H; Schretter C; Clarke R; Cai Y; Fitzgerald M; Lee KS
    Brain Res; 2014 Oct; 1583():245-54. PubMed ID: 25128603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-sodium crocetinate and hemorrhagic shock.
    Stennett AK; Murray RJ; Roy JW; Gainer JL
    Shock; 2007 Sep; 28(3):339-44. PubMed ID: 17545940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice.
    Deng J; Xiong L; Zuo Z
    J Neurosci Res; 2015 Apr; 93(4):615-22. PubMed ID: 25491171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-sodium crocetinate for treating hypoxia/ischemia.
    Gainer JL
    Expert Opin Investig Drugs; 2008 Jun; 17(6):917-24. PubMed ID: 18491992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-sodium crocetinate does not affect oxygen uptake in rats during treadmill running.
    Kemi OJ; Ellingsen O
    Scand J Clin Lab Invest; 2005; 65(7):577-84. PubMed ID: 16271989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSC for hemorrhagic shock: effects on cytokines and blood pressure.
    Stennett AK; Gainer JL
    Shock; 2004 Dec; 22(6):569-74. PubMed ID: 15545830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reflow as a therapy for ischemic brain injury.
    Manabe H; Wang Y; Yoshimura R; Cai Y; Fitzgerald M; Clarke R; Lee KS
    Acta Neurochir Suppl; 2011; 110(Pt 2):87-91. PubMed ID: 21125451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crocetin and related oxygen diffusion-enhancing compounds: Review of chemical synthesis, pharmacology, clinical development, and novel therapeutic applications.
    Shah HM; Jain AS; Joshi SV; Kharkar PS
    Drug Dev Res; 2021 Nov; 82(7):883-895. PubMed ID: 33817811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.
    Sheehan J; Ionescu A; Pouratian N; Hamilton DK; Schlesinger D; Oskouian RJ; Sansur C
    J Neurosurg; 2008 May; 108(5):972-8. PubMed ID: 18447715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor.
    Sheehan JP; Popp B; Monteith S; Toulmin S; Tomlinson J; Martin J; Cifarelli CP; Lee DH; Park DM
    J Neurosurg; 2011 Oct; 115(4):749-53. PubMed ID: 21682571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSC and hemorrhagic shock.
    Giassi LJ; Gainer JL
    Adv Exp Med Biol; 2003; 540():55-60. PubMed ID: 15174602
    [No Abstract]   [Full Text] [Related]  

  • 16. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perihematomal Cellular Injury Is Reduced by Trans-sodium Crocetinate in a Model of Intracerebral Hemorrhage.
    Wang Y; Schretter C; Clarke R; Lee KS
    Mol Neurobiol; 2015 Oct; 52(2):985-9. PubMed ID: 26050085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Anti-hypoxia Potentials of Trans-sodium Crocetinate in Hypoxiarelated Diseases: A Review.
    Klunko NS; Achmad H; Abdullah TM; Mohammed S; Saha I; Salim KS; Obaid RF; Romero-Parra RM; Al-Hasnawi SS; Al-Janabi WH; Farhood B
    Curr Radiopharm; 2024; 17(1):30-37. PubMed ID: 37877507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-sodium crocetinate restores blood pressure, heart rate, and plasma lactate after hemorrhagic shock.
    Giassi LJ; Gilchrist MJ; Graham MC; Gainer JL
    J Trauma; 2001 Nov; 51(5):932-8. PubMed ID: 11706343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. trans-Sodium crocetinate and diffusion enhancement.
    Stennett AK; Dempsey GL; Gainer JL
    J Phys Chem B; 2006 Sep; 110(37):18078-80. PubMed ID: 16970413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.